XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Series A Preferred Stock
Series B Preferred Stock
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Common Stock
Common Stock
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Common Stock
Additional Paid-in Capital
Series B Preferred Stock
Accumulated Other Comprehensive Income
Accumulated Deficit
Accumulated Deficit
Common Stock
Accumulated Deficit
Series A Preferred Stock
Accumulated Deficit
Series B Preferred Stock
Total Stockholders’ Equity
Total Stockholders’ Equity
Common Stock
Total Stockholders’ Equity
Series A Preferred Stock
Total Stockholders’ Equity
Series B Preferred Stock
Non-controlling interest
Beginning balance (in shares) at Dec. 31, 2021         6,799,467 4,503,893   103,900,452                          
Beginning balance at Dec. 31, 2021 $ 1,626,635       $ 68 $ 45   $ 2,369 $ 2,675,154     $ 15,546 $ (1,072,462)       $ 1,620,720       $ 5,915
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Issuance of stock, net (in shares)           97,384                              
Issuance of stock, net       $ 2,396   $ 1         $ 2,395                 $ 2,396  
Dividends declared, common stock   $ (41,566)                       $ (41,566)       $ (41,566)      
Dividends declared, preferred stock     $ (3,081) (1,977)                     $ (3,081) $ (1,977)     $ (3,081) (1,977)  
Equity-based compensation, net of forfeitures (in shares)             9,261                            
Equity-based compensation, net of forfeitures 2,727           $ 0   481               481       2,246
Distributions to non-controlling interest holders (100)                       (100)       (100)        
Net income (loss) 10,541                       10,541       10,541        
Cumulative translation adjustment (10,285)                     (10,285)         (10,285)        
Designated derivatives, fair value adjustments 10,048                     10,048         10,048        
Ending balance (in shares) at Mar. 31, 2022         6,799,467 4,601,277   103,909,713                          
Ending balance at Mar. 31, 2022 1,595,338       $ 68 $ 46   $ 2,369 2,678,030     15,309 (1,108,645)       1,587,177       8,161
Beginning balance (in shares) at Dec. 31, 2022         6,799,467 4,695,887   104,141,899                          
Beginning balance at Dec. 31, 2022 1,453,919       $ 68 $ 47   $ 2,371 2,683,169     1,147 (1,247,781)       1,439,021       14,898
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Issuance of stock, net   (21)               $ (21)               (21)      
Dividends declared, common stock   $ (41,677)                       $ (41,677)       $ (41,677)      
Dividends declared, preferred stock     $ (3,081) $ (2,018)                     $ (3,081) $ (2,018)     $ (3,081) $ (2,018)  
Equity-based compensation, net of forfeitures (in shares)             16,011                            
Equity-based compensation, net of forfeitures 2,925               679               679       2,246
Distributions to non-controlling interest holders (100)                       (100)       (100)        
Net income (loss) (890)                       (890)       (890)        
Cumulative translation adjustment 6,520                     6,520         6,520        
Designated derivatives, fair value adjustments (3,965)                     (3,965)         (3,965)        
Ending balance (in shares) at Mar. 31, 2023         6,799,467 4,695,887   104,157,910                          
Ending balance at Mar. 31, 2023 $ 1,411,612       $ 68 $ 47   $ 2,371 $ 2,683,827     $ 3,702 $ (1,295,547)       $ 1,394,468       $ 17,144